Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision | Next revision Both sides next revision | ||
publications [2020/01/10 10:01] ramirez [2018] |
publications [2020/01/10 10:02] ramirez [2019] |
||
---|---|---|---|
Line 36: | Line 36: | ||
Björnsdóttir ES, [[people:emartins|Martins ER]], Erlendsdóttir H, Haraldsson G, [[people:jmelocristino|Melo-Cristino J]], [[people:ramirez|Ramirez M]], Kristinsson KG. 2019. <fc #0000FF>Group B streptococcal neonatal and early infancy infections in Iceland 1976 - 2015</fc>. Pediatr Infect Dis J. 38:620–624. [[http://www.ncbi.nlm.nih.gov/pubmed/30299423|(PMID: 30299423)]] | Björnsdóttir ES, [[people:emartins|Martins ER]], Erlendsdóttir H, Haraldsson G, [[people:jmelocristino|Melo-Cristino J]], [[people:ramirez|Ramirez M]], Kristinsson KG. 2019. <fc #0000FF>Group B streptococcal neonatal and early infancy infections in Iceland 1976 - 2015</fc>. Pediatr Infect Dis J. 38:620–624. [[http://www.ncbi.nlm.nih.gov/pubmed/30299423|(PMID: 30299423)]] | ||
+ | |||
+ | Huizenga E, van der Ende J, Zwinkels N, Jimissa A, van der Ende-Bouwman C, van Rooijen R, Kargbo B, Agnandji ST, Hänscheid T, Goorhuis A, Grobusch MP. 2018. <fc #0000FF>A modified case definition to facilitate essential hospital care during Ebola outbreaks</fc>. Clin Infect Dis. 68:1763–1768. [[http://www.ncbi.nlm.nih.gov/pubmed/30239602|(PMID: 30239602)]] | ||
===== 2018 ===== | ===== 2018 ===== | ||
Caneiras C, Calisto F, Jorge da Silva G, Lito L, [[people:jmelocristino|Melo-Cristino J]], Duarte A. 2018. <fc #0000FF>First description of colistin and tigecycline-resistant //Acinetobacter baumannii// producing KPC-3 carbapenemase in Portugal</fc>. Antibiotics 7. [[https://doi.org/10.3390/antibiotics7040096|doi:10.3390/antibiotics7040096]] [[http://www.ncbi.nlm.nih.gov/pubmed/30404152|(PMID: 30404152)]] | Caneiras C, Calisto F, Jorge da Silva G, Lito L, [[people:jmelocristino|Melo-Cristino J]], Duarte A. 2018. <fc #0000FF>First description of colistin and tigecycline-resistant //Acinetobacter baumannii// producing KPC-3 carbapenemase in Portugal</fc>. Antibiotics 7. [[https://doi.org/10.3390/antibiotics7040096|doi:10.3390/antibiotics7040096]] [[http://www.ncbi.nlm.nih.gov/pubmed/30404152|(PMID: 30404152)]] |